Elsmarieke Van de Giessen
Affiliations: | Academic Medical Center Amsterdam, Amsterdam, Netherlands |
Google:
"Elsmarieke Van de Giessen"Mean distance: 18.76 (cluster 48) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Reneman L, van der Pluijm M, Schrantee A, et al. (2021) Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging. European Journal of Radiology. 140: 109752 |
Koenders L, Machielsen MW, van der Meer FJ, et al. (2015) Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders. Journal of Psychiatry & Neuroscience : Jpn. 40: 197-206 |
Bongers P, van de Giessen E, Roefs A, et al. (2015) Being impulsive and obese increases susceptibility to speeded detection of high-calorie foods. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 34: 677-85 |
van de Giessen E, Celik F, Schweitzer DH, et al. (2014) Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity. Journal of Psychopharmacology (Oxford, England). 28: 866-73 |
de Weijer BA, van de Giessen E, Janssen I, et al. (2014) Striatal dopamine receptor binding in morbidly obese women before and after gastric bypass surgery and its relationship with insulin sensitivity. Diabetologia. 57: 1078-80 |
van de Giessen E, Hesse S, Caan MW, et al. (2013) No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers. Neuroimage. 64: 61-7 |
van de Giessen E, la Fleur SE, Eggels L, et al. (2013) High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity. International Journal of Obesity (2005). 37: 754-7 |
Crunelle CL, van de Giessen E, Schulz S, et al. (2013) Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability. Addiction Biology. 18: 908-11 |
van de Giessen E, Nimgaonkar VL, Watson AM, et al. (2012) Association tests of striatal DAT availability and SNPs that impact a novel splice variant in the DAT gene. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 839 |
van de Giessen E, la Fleur SE, de Bruin K, et al. (2012) Free-choice and no-choice high-fat diets affect striatal dopamine D2/3 receptor availability, caloric intake, and adiposity. Obesity (Silver Spring, Md.). 20: 1738-40 |